iCoreConnect Inc.

ICCT Healthcare Health Information Services

iCoreConnect Inc.’s revenue for fiscal 2024 (year ended December 2024) was $10.7 million, up 31.8% from fiscal 2023. In the quarter to December 2024, revenue fell 12.4%, EPS grew 92.5% and free cash flow grew 91.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

0.00 0.00 NaN
Market cap
$800.0K
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
3/9
Altman Z
−45.87
Beneish M
−26.03
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 0.80
Revenue 10.75
Net Income (33.20)
Free Cash Flow (2.90)
Net Debt 1.78
Current Ratio 0.10 (below 1: weak)
Debt/Equity (0.20) (negative: negative equity)
P/E ratio 0.00
Fwd P/E —
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2021 2022 2023 2024
Cash 0 0 1 0
Receivables 1 0 1 1
Inventory — — — —
Other — — — —
1 1 4 1
2021 2022 2023 2024
Payables 0 2 3 5
ST’ Debt — — — —
Other — — — —
0 7 9 12

Compound Annual Growth %

10y 5y 3y
Sales — 60.34% 29.43%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’24 3 3 3 2 11
’23 2 2 2 2 8
’22 — — 2 6 8
’21 — — — — 5
’20 — — — — 2
’19 — — — — 1
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’24 (1) 0 0 (2) (3)
’23 (1) (1) 0 (7) (9)
’22 0 0 (1) 0 (1)
’21 — — — 0 0
’20 — — — — (1)
’19 — — — — (2)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’24 (1) 0 (1) (1) (3)
’23 (1) (1) 0 (7) (10)
’22 0 0 (1) 0 (2)
’21 — — — 0 0
’20 — — — — (1)
’19 — — — — (2)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’24 (10.20) (22.00) (12.20) (1.41) (45.78)
’23 (5.20) (8.25) (10.80) (18.80) (43.40)
’22 (1.03) (0.87) (4.85) (14.33) (21.08)
’21 — — — — (1.18)
’20 — — — — (1.36)
’19 — — — — (1.52)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Trend 2025e 2026e 2027e
Price, $
Price, $ Low — 106.38 0.18 0.06 0.18 18.08 42.07 6.03 18.22 2.31

Analyst estimates 2025–2027

Powerpack
High — 3,191.49 1,170.21 1.01 1,199.57 596.80 237.53 89.10 414.00 37.40
People
People Employees — — — — — — — 2 70 72
Revenue/emp, $m — — — 0.00 0.00 0.00 0.00 3.99 0.12 0.15
Income, $m
Income, $m Revenue — — — 1 1 2 5 8 8 11
Gross margin, % — — — 21.40 5.33 9.83 39.25 71.92 75.11 76.77
EBT — — — (5) (3) (3) 0 (6) (16) (31)
EBT margin, % — — — (476.58) (294.18) (164.40) (0.04) (76.11) (190.78) (289.93)
Net income — — — (5) (3) (3) 0 (6) (16) (33)
Depreciation — — — 0 1 1 0 1 1 3
Per share, $
Per share, $ Revenue — — — 0.73 0.52 0.83 1.01 27.70 22.18 14.82
Earnings — — — (3.58) (1.52) (1.36) (1.18) (0.25) (43.40) (45.78)
Cash flow — — — (1.32) (0.85) (0.50) 0.00 (4.41) (24.01) (4.45)
Capex — — — 0.00 0.00 0.00 0.00 (1.02) (2.34) 0.46
Free cash flow — — — (1.32) (0.85) (0.50) 0.00 (5.43) (26.35) (4.00)
Book value — — — (0.64) 0.24 (0.25) 0.00 (8.67) 12.09 (13.51)
Shares, m — — — 1 2 3 5 0 0 1
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S — — — 0.00 0.00 0.00 0.00 0.00 1.15 0.17
P/B — — — 3.34 3.34 3.34 3.34 0.00 2.10 0.00
EV/Sales — — — 0.00 0.00 0.00 0.00 0.00 1.17 0.33
EV/FCF — — — 0.00 0.00 0.00 0.00 (18.49) (0.98) (1.24)
Cash, $m
Cash, $m Operating cash flow — — — (2) (2) (1) 0 (1) (9) (3)
Capex — — — 0 0 (1) 0 0 (1) 0
Free cash flow — — — (2) (2) (1) 0 (2) (10) (3)
Balance, $m
Balance, $m Working capital — — — (2) (1) (3) 1 (6) (5) (11)
Total debt — — — 2 1 2 2 1 1 2
Net debt — — — 2 1 2 1 1 0 2
Shareholders’ equity — — — (1) 0 (1) 0 (3) 4 (10)
Returns, %
Returns, % ROA — — — 0.00 (140.15) (133.95) (0.13) (170.32) (143.15) (310.62)
ROIC — — — 0.00 0.00 0.00 (0.08) 0.00 (138.28) 0.00
ROE — — — 0.00 1,210.14 4,260.16 0.57 628.75 (1,639.33) 1,240.88
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2024 · latest quarter Dec 2024

Charts ten years each

iCoreConnect Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
ZCMD Zhongchao Inc. $6.2M — (loss-making) — +20.44% (above 0%: growing) −550.00% (below 0%: shrinking) +191.85% (above 0%: growing) 41.67% 0.00% Compare
ACON Aclarion, Inc. $5.6M — (loss-making) — (loss-making) +30.57% (above 0%: growing) n/m −41.41% (below 0%: shrinking) 32.94% (11,506.75%) Compare
VSEED VSee Health, Inc. $2.8M — (loss-making) — (loss-making) +48.02% (above 0%: growing) n/m −257.62% (below 0%: shrinking) 13.20% (172.69%) Compare
LGMK LogicMark, Inc. $1.7M — (loss-making) — (loss-making) +17.39% (above 0%: growing) n/m +96.41% (above 0%: growing) 70.71% (47.60%) Compare
MSPR MSP Recovery, Inc. $1.5M — (loss-making) — −94.60% (below 0%: shrinking) n/m +60.88% (above 0%: growing) (26.77%) (62,501.52%) Compare
MNDR Mobile-health Network Solutions $1.3M — — — — — — — Compare
WORX SCWorx Corp. $1.1M 0.1× — (loss-making) +3.43% (above 0%: growing) n/m +87.99% (above 0%: growing) 46.80% (17.14%) Compare
ICCT iCoreConnect Inc. $800.0K — (loss-making) — −12.37% (below 0%: shrinking) n/m +91.63% (above 0%: growing) 74.39% (129.31%)
Median of peers $2.3M — — +17.39% — +60.88% 32.94% (172.69%)

All 51 Health Information Services stocks →

iCoreConnect Inc. (ICCT) key facts

  • Strength: iCoreConnect Inc.’s revenue for fiscal 2024 (year ended December 2024) was $10.7 million, up 31.8% from fiscal 2023.
  • iCoreConnect Inc. (ICCT) is a Health Information Services company in the Healthcare sector.
  • Return on equity was 1,240.9% and debt-to-equity -0.20.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −45.87 (distress zone) for fiscal 2024.

Source: company filings (standardised) and stockrow calculations.

iCoreConnect Inc. (ICCT) Latest News

19 Dec

stockrow.com/ICCT · Data as of Dec 31, 2024 · For information only; not investment advice. · © 2026 stockrow.com